228 related articles for article (PubMed ID: 38545295)
21. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
22. siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles.
Sakurai Y; Yoshikawa K; Arai K; Kazaoka A; Aoki S; Ito K; Nakai Y; Tange K; Furihata T; Tanaka H; Akita H
J Control Release; 2023 Jan; 353():125-133. PubMed ID: 36414194
[TBL] [Abstract][Full Text] [Related]
23. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
24. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
[TBL] [Abstract][Full Text] [Related]
25. Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.
Scalzo S; Santos AK; Ferreira HAS; Costa PA; Prazeres PHDM; da Silva NJA; Guimarães LC; E Silva MM; Rodrigues Alves MTR; Viana CTR; Jesus ICG; Rodrigues AP; Birbrair A; Lobo AO; Frezard F; Mitchell MJ; Guatimosim S; Guimaraes PPG
Int J Nanomedicine; 2022; 17():2865-2881. PubMed ID: 35795081
[TBL] [Abstract][Full Text] [Related]
26. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
27. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
28. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles.
Swart LE; Fens MHAM; van Oort A; Waranecki P; Mata Casimiro LD; Tuk D; Hendriksen M; van den Brink L; Schweighart E; Seinen C; Nelson R; Krippner-Heidenreich A; O'Toole T; Schiffelers RM; Kooijmans S; Heidenreich O
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376052
[TBL] [Abstract][Full Text] [Related]
29. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
30. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
31. Design of abiotic polymer ligand-decorated lipid nanoparticles for effective neutralization of target toxins in the blood.
Koide H; Yamauchi I; Hoshino Y; Yasuno G; Okamoto T; Akashi S; Saito K; Oku N; Asai T
Biomater Sci; 2021 Aug; 9(16):5588-5598. PubMed ID: 34241600
[TBL] [Abstract][Full Text] [Related]
32. Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.
Piao L; Li H; Teng L; Yung BC; Sugimoto Y; Brueggemeier RW; Lee RJ
Nanomedicine; 2013 Jan; 9(1):122-9. PubMed ID: 22542825
[TBL] [Abstract][Full Text] [Related]
33. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles.
Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542
[TBL] [Abstract][Full Text] [Related]
34. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.
Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D
Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657
[TBL] [Abstract][Full Text] [Related]
36. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
37. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
[TBL] [Abstract][Full Text] [Related]
38. Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probe.
Zhao B; Kamanzi A; Zhang Y; Chan KYT; Robertson M; Leslie S; Cullis PR
Biosens Bioelectron; 2024 May; 251():116065. PubMed ID: 38330772
[TBL] [Abstract][Full Text] [Related]
39. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.
Zhang M; Jiang H; Wu L; Lu H; Bera H; Zhao X; Guo X; Liu X; Cun D; Yang M
J Control Release; 2022 Dec; 352():422-437. PubMed ID: 36265740
[TBL] [Abstract][Full Text] [Related]
40. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
Zhang J; Haas RM; Leone AM
Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
